BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-10 out of 10 found
  Current Search:  immunologic: 10     

HTML
100%
Gene profiling of patients with chronic fatigue syndrome/myalgic encephalomyelitis - Source: Curren
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a multisystem disease, the pathogenesis of which remains undetermined.

Following two microarray studies, we reported the differential expression of 88 human genes in patients...

Pro Health Network:  Nov 22 2008 11:47PM
Matching: immunologic
Find similar documents
HTML
100%
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
Stuve O et al.

- This is the first long-term follow-up of patients who discontinued natalizumab.

We did not observe a clinical, radiographic, or immunologic rebound phenomenon after discontinuation of natalizumab therapy.

...

MDLinx:  Nov 22 2008 2:45AM
Matching: immunologic
Find similar documents
HTML
100%
Immunologic changes in children with egg allergy ingesting extensively heated egg
Lemon-Mule H et al.

- The majority of subjects with egg allergy were tolerant of heated egg.

Continued ingestion of heated egg was well tolerated and associated with immunologic changes that paralleled the changes observed with the...

MDLinx:  Nov 19 2008 12:11AM
Matching: immunologic
Find similar documents
HTML
100%
TopAbstracts in AIDS and HIV 11/10/2008
TopAbstracts in AIDS and HIV are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.

Over 2000 peer-reviewed...

Doctors Guide:  Nov 11 2008 1:37PM
Matching: immunologic
Find similar documents
HTML
100%
Immunologic and clinical status 14 months after cessation of natalizumab therapy
Stuve O et al.

- This is the first long-term follow-up of patients who discontinued natalizumab.

We did not observe a clinical, radiographic, or immunologic rebound phenomenon after discontinuation of natalizumab therapy.

--- NEURO...

MDLinx:  Nov 7 2008 1:30PM
Matching: immunologic
Find similar documents
HTML
100%
A Comparison of Clinical and Immunologic Features in Children and Older Patients Hospitalized With Severe Chol
Chowdhury F et al.

- Although children developed vigorous vibriocidal and CTB-specific responses following infection, they had lessened responses to LPS and TcpA compared with older patients, as well as lessened responses to vaccination.

MDLinx:  Nov 3 2008 9:40PM
Matching: immunologic
Find similar documents
HTML
100%
96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sul
PRINCETON, N.J.-(Business Wire)-October 26, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week data from the CASTLE study, in which 74 percent of the 440 patients in the REYATAZ (atazanavir sulfate)/r arm achieved an...
DiGiTAL50:  Oct 26 2008 5:33PM
Matching: immunologic
Find similar documents
HTML
100%
96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sul
Data continue to show differences in gastrointestinal and lipid effects among study population PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY - News) today announced 96-week data from the CASTLE study, in which 74...
Business Wire via Yahoo!:  Oct 26 2008 4:37PM
Matching: immunologic
Find similar documents
HTML
100%
96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sul
2008-10-2612:30ET - News Release Data continue to show differences in gastrointestinal and lipid effects among study population PRINCETON, N.J.

-- (Business Wire) Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week data from...

Stockwatch:  Oct 26 2008 4:34PM
Matching: immunologic
Find similar documents
HTML
100%
Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology An
Study Showed Larazotide Acetate Prevented Immunologic Changes Induced by Gluten in Patients with Celiac Disease Additional Data Indicates Potential in Treating Inflammatory Bowel Disease ORLANDO, Fla., Oct.

7 /PRNewswire/ -- Alba...

Pharma Live:  Oct 7 2008 3:20PM
Matching: immunologic
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.